Day: October 1, 2024

Palatin Reports Fourth Quarter and Fiscal Year Ended 2024 Financial Results, Provides Update on Clinical Programs, Strategic Priorities, and Anticipated Milestones

Obesity: Phase 2 Clinical Study with Melanocortin-4 Receptor (MC4R) Agonist plus Glucagon Like Peptide-1 (GLP-1)Patient Dosing Commenced 3Q Calendar Year...

Chasing efficiency and digital maturity: CRB’s new Horizons report finds biopharma manufacturers going all-in on digitalization, continuous manufacturing and more

Meeting patient demand for breakthrough drugs and therapies requires new efficiencies on the manufacturing floor, and the industry is responding...

The Craneware Group Announces Strategic Partnership with Microsoft, Featuring Three Innovative Solutions on the Microsoft Azure Marketplace

DEERFIELD BEACH, Fla., Oct. 1, 2024 /PRNewswire/ -- The Craneware Group™, a leader in healthcare financial performance and 340B management,...

Phio Pharmaceuticals Announces Upcoming Presentation at ASGCT’s 2024 Advancing Gene + Cell Therapies for Cancer Conference

Marlborough, Massachusetts--(Newsfile Corp. - October 1, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary...

Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US

The cooperation between Laxxon and Adare enables the clinical and commercial production of advanced drug delivery systems at Adare’s cGMP...

error: Content is protected !!